AAAAAA

   
Results: 1-22 |
Results: 22
Anaplastic lymphoma kinase proteins and malignancy
Authors: Pulford, K Morris, SW Mason, DY
Citation: K. Pulford et al., Anaplastic lymphoma kinase proteins and malignancy, CURR OPIN H, 8(4), 2001, pp. 231-236
Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the anti proliferative effect of p27(Kip1)
Authors: Turturro, F Frist, AY Arnold, MD Seth, P Pulford, K
Citation: F. Turturro et al., Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the anti proliferative effect of p27(Kip1), ONCOGENE, 20(33), 2001, pp. 4466-4475
Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma
Authors: Tort, F Pinyol, M Pulford, K Roncador, G Hernandez, L Nayach, I Kluin-Nelemans, HC Kluin, P Touriol, C Delsol, G Mason, D Campo, E
Citation: F. Tort et al., Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma, LAB INV, 81(3), 2001, pp. 419-426
ALK is not expressed in Hodgkin disease
Authors: Camilleri-Broet, S Audouin, J Ferme, C Briere, J Pulford, K Gaulard, P Divine, M Macintyre, E Delsol, G Berger, F
Citation: S. Camilleri-broet et al., ALK is not expressed in Hodgkin disease, BLOOD, 97(6), 2001, pp. 1901-1902
Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins
Authors: Boulland, ML Wechsler, J Bagot, M Pulford, K Kanavaros, P Gaulard, P
Citation: Ml. Boulland et al., Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins, HISTOPATHOL, 36(2), 2000, pp. 136-144
ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occursbefore dissemination
Authors: ten Berge, RL Oudejans, JJ Ossenkoppele, GJ Pulford, K Willemze, R Falini, B Chott, A Meijer, CJLM
Citation: Rl. Ten Berge et al., ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occursbefore dissemination, J CLIN PATH, 53(6), 2000, pp. 445-450
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma
Authors: Trinei, M Lanfrancone, L Campo, E Pulford, K Mason, DY Pelicci, PG Falini, B
Citation: M. Trinei et al., A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma, CANCER RES, 60(4), 2000, pp. 793-798
Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma
Authors: Pulford, K Falini, B Banham, AH Codrington, D Roberton, H Hatton, C Mason, DY
Citation: K. Pulford et al., Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma, BLOOD, 96(4), 2000, pp. 1605-1607
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
Authors: Stein, H Foss, HD Durkop, H Marafioti, T Delsol, G Pulford, K Pileri, S Falini, B
Citation: H. Stein et al., CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features, BLOOD, 96(12), 2000, pp. 3681-3695
Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)
Authors: Touriol, C Greenland, C Lamant, L Pulford, K Bernard, F Rousset, T Mason, DY Delsol, G
Citation: C. Touriol et al., Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like), BLOOD, 95(10), 2000, pp. 3204-3207
Expression of the ALK tyrosine kinase gene in neuroblastoma
Authors: Lamant, L Pulford, K Bischof, D Morris, SW Mason, DY Delsol, G Mariame, B
Citation: L. Lamant et al., Expression of the ALK tyrosine kinase gene in neuroblastoma, AM J PATH, 156(5), 2000, pp. 1711-1721
Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily
Authors: Banham, AH Colonna, M Cella, M Micklem, KJ Pulford, K Willis, AC Mason, DY
Citation: Ah. Banham et al., Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily, J LEUK BIOL, 65(6), 1999, pp. 841-845
Immunohistochemical screening for oncogenic tyrosine kinase activation
Authors: Pulford, K Delsol, G Roncador, G Biddolph, S Jones, M Mason, DY
Citation: K. Pulford et al., Immunohistochemical screening for oncogenic tyrosine kinase activation, J PATHOLOGY, 187(5), 1999, pp. 588-593
A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas
Authors: Dukers, DF ten Berge, RL Oudejans, JJ Pulford, K Hayes, D Misere, JFMM Ossenkoppele, GJ Jaspars, LH Willemze, R Meijer, CJLM
Citation: Df. Dukers et al., A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas, J CLIN PATH, 52(2), 1999, pp. 129-136
Lymphocyte-specific protein 1: A specific marker of human leucocytes
Authors: Pulford, K Jones, M Banham, AH Haralambieva, E Mason, DY
Citation: K. Pulford et al., Lymphocyte-specific protein 1: A specific marker of human leucocytes, IMMUNOLOGY, 96(2), 1999, pp. 262-271
TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations
Authors: Hernandez, L Pinyol, M Hernandez, S Bea, S Pulford, K Rosenwald, A Lamant, L Falini, B Ott, G Mason, DY Delsol, G Campo, E
Citation: L. Hernandez et al., TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations, BLOOD, 94(9), 1999, pp. 3265-3268
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
Authors: Falini, B Pulford, K Pucciarini, A Carbone, A De Wolf-Peeters, C Cordell, J Fizzotti, M Santucci, A Pelicci, PG Pileri, S Campo, E Ott, G Delsol, G Mason, DY
Citation: B. Falini et al., Lymphomas expressing ALK fusion protein(s) other than NPM-ALK, BLOOD, 94(10), 1999, pp. 3509-3515
t(1;2)(q21;p23) and t(2;3)(p23;q21): Two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma
Authors: Rosenwald, A Ott, G Pulford, K Katzenberger, T Kuhl, J Kalla, J Ott, MM Mason, DY Muller-Hermelink, HK
Citation: A. Rosenwald et al., t(1;2)(q21;p23) and t(2;3)(p23;q21): Two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, BLOOD, 94(1), 1999, pp. 362-364
A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation
Authors: Lamant, L Dastugue, N Pulford, K Delsol, G Mariame, B
Citation: L. Lamant et al., A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation, BLOOD, 93(9), 1999, pp. 3088-3095
Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma
Authors: ten Berge, RL Dukers, DF Oudejans, JJ Pulford, K Ossenkoppele, GJ de Jong, D Misere, JFMM Meijer, CJLM
Citation: Rl. Ten Berge et al., Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma, BLOOD, 93(8), 1999, pp. 2688-2696
The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma
Authors: Jones, D Fletcher, CDM Pulford, K Shahsafaei, A Dorfman, DM
Citation: D. Jones et al., The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma, BLOOD, 93(10), 1999, pp. 3487-3493
Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma
Authors: Pulford, K Falini, B Cordell, J Rosenwald, A Ott, G Muller-Hermelink, HK MacLennan, KA Lamant, L Carbone, A Campo, E Mason, DY
Citation: K. Pulford et al., Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma, AM J PATH, 154(6), 1999, pp. 1657-1663
Risultati: 1-22 |